Yahoo Web Search

Search results

    • UPDATE 1-Merck's endometrial cancer therapy fails trial

      Reuters via Yahoo Finance· 15 minutes ago

      Merck said on Thursday its therapy did not meet the main goal of disease-free survival in certain patients with endometrial cancer during a late-stage trial. The drugmaker's Keytruda therapy ...